Ultragenyx Pharmaceutical Investor Relations Material

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for rare and ultra-rare genetic diseases. The company's focus includes treatments for metabolic disorders, bone diseases, and other conditions with significant unmet medical needs. Ultragenyx leverages innovative research and targeted approaches to address complex diseases that often lack effective therapies.The company is headquartered in Novato, California, and its shares are listed on the NASDAQ.